|
Mylan to Sell Generic Orapred in 2014, Expects First-Filer Exclusivity
Mylan can begin selling a generic version of Shionogi Pharma’s lung drug Orapred ODT in April 2014 or earlier under certain circumstances per an agreement with the brand drug’s maker.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives